A preclinical randomized controlled multi-centre trial of anti-interleukin-17a treatment for acute ischaemic stroke

HIGHLIGHTS

  • who: Mathias Gelderblom from the (UNIVERSITY) have published the research work: A preclinical randomized controlled multi-centre trial of anti-interleukin-17A treatment for acute ischaemic stroke, in the Journal: (JOURNAL)

SUMMARY

    @@

ACRONYMS

LAY DEFINITIONS

  • stroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs
  • interleukin-17A: A . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?